Advanced search
Publication Cover
Neuro-Ophthalmology Volume 48, 2024 - Issue 3
Submit an article Journal homepage
43
Views
0
CrossRef citations to date
0
Altmetric
Photo Essay

SD-OCT Imaging of Macular Changes in Fabry Disease: A Case Report

Stephanie S. Moona Concord Clinical School, The University of Sydney, Sydney, AustraliaCorrespondence[email protected]
View further author information
,
Christopher A. Ovensb Save Sight Institute, Faculty of Health and Medicine, The University of Sydney, Sydney, AustraliaView further author information
,
Gerard Reidb Save Sight Institute, Faculty of Health and Medicine, The University of Sydney, Sydney, AustraliaView further author information
&
Clare L. Fraserb Save Sight Institute, Faculty of Health and Medicine, The University of Sydney, Sydney, AustraliaView further author information
Pages 198-203 | Received 26 Jul 2023, Accepted 02 Jan 2024, Published online: 26 Jan 2024

References

  • Wanner C, Arad M, Baron R, et al. European expert consensus statement on therapeutic goals in Fabry disease. Mol Genet Metab. 2018;124(3):189–203. doi:10.1016/j.ymgme.2018.06.004.
  • Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5(1):30. doi:10.1186/1750-1172-5-30.
  • Choi JH, Lee BH, Heo SH, et al. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: underdiagnosis of late-onset phenotype. Medicine. 2017;96(29):e7387. doi:10.1097/MD.0000000000007387.
  • Duro G, Zizzo C, Cammarata G, et al. Mutations in the GLA gene and LysoGb3: is it really Anderson-Fabry disease? Int J Mol Sci. 2018;19(12):3726. doi:10.3390/ijms19123726.
  • Michaud L, Virgili G. Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease. PLoS One. 2019;14(6):e0213329. doi:10.1371/journal.pone.0213329.
  • Sodi A, Ioannidis AS, Mehta A, Davey C, Beck M, Pitz S. Ocular manifestations of Fabry’s disease: data from the Fabry outcome survey. Br J Ophthalmol. 2007;91(2):210–214. doi:10.1136/bjo.2006.100602.
  • Germain DP, Fouilhoux A, Decramer S, et al. Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients. Clin Genet. 2019;96(2):107–117. doi:10.1111/cge.13546.
  • Weidemann F, Jovanovic A, Herrmann K, Vardarli I. Chaperone therapy in Fabry disease. Int J Mol Sci. 2022;23(3):1887. doi:10.3390/ijms23031887.
  • Schuman JS. Spectral domain optical coherence tomography for glaucoma (an AOS thesis). Trans Am Ophthalmol Soc. 2008;106:426–58.
  • Atiskova Y, Rassuli R, Koehn AF, et al. Retinal hyperreflective foci in Fabry disease. Orphanet J Rare Dis. 2019;14(1):296. doi:10.1186/s13023-019-1267-2.
  • Minnella AM, Barbano L, Verrecchia E, et al. Macular impairment in Fabry disease: a morpho-functional assessment by swept-source OCT angiography and focal electroretinography. Research support, non-U.S. Gov’t. Invest Ophthalmol Vis Sci. 2019;60(7):2667–2675. doi:10.1167/iovs.18-26052.
  • Jardim L, Vedolin L, Schwartz IV, et al. CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy. J Inherit Metab Dis. 2004;27(2):229–240. doi:10.1023/B:BOLI.0000028794.04349.91.
  • Jardim LB, Aesse F, Vedolin LM, et al. White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up. Arq NeuroPsiquiatr. 2006;64(3B):711–7. doi:10.1590/s0004-282x2006000500002.
  • Buechner S, Moretti M, Burlina AP, et al. Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry. 2008;79(11):1249–54. doi:10.1136/jnnp.2008.143693.
  • Campbell JP, Zhang M, Hwang TS, et al. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep. 2017;7(1):42201. doi:10.1038/srep42201.
  • Dinu IR, Firu SG. Fabry disease - current data and therapeutic approaches. Review. Rom J Morphol Embryol. 2021;62(1):5–11. doi:10.47162/RJME.62.1.01.
  • Pitz S, Kalkum G, Arash L, et al. Ocular signs correlate well with disease severity and genotype in Fabry disease. Research support, non-U.S. Gov’t. PLoS One. 2015;10(3):e0120814. doi:10.1371/journal.pone.0120814.
  • Sodi A, Ioannidis A, Pitz S. Ophthalmological manifestations of Fabry disease. Review. Oxford PharmaGenesis. 2006;26:1.
  • Sivley MD, Benjamin WJ. Fabry keratopathy: manifestations and changes over time. Research support, non-U.S. Gov’t. Br J Ophthalmol. 2020;104(8):1148–1155. doi:10.1136/bjophthalmol-2019-314906.
  • Hollander DA, Aldave AJ. Drug-induced corneal complications. Curr Opin Ophthalmol. 2004;15(6):541–8. doi:10.1097/01.icu.0000143688.45232.15.
  • Saeed D, Hussain A. Ribociclib-associated vortex keratopathy. Can J Ophthalmol. 2020;55(4):e140–e142. doi:10.1016/j.jcjo.2019.11.003.
  • Chong EM, Campbell RJ, Bourne WM. Vortex keratopathy in a patient with multiple myeloma. Cornea. 1997;16(5):592–4. doi:10.1097/00003226-199709000-00019.
  • Rombach SM, Smid BE, Bouwman MG, Linthorst GE, Dijkgraaf MG, Hollak CE. Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain. Orphanet J Rare Dis. 2013;8:47. doi:10.1186/1750-1172-8-47.
  • Weidemann F, Niemann M, Stork S, et al. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med. 2013;274(4):331–41. doi:10.1111/joim.12077.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.